>A small, struggling MA biotech gets unsolicited buyout offer for approx 300% above current trading at time...<
And if that highly unlikely scenario occurred here, we'd be at the magnificent figure of 0.39 PPS.
For new buyers coming in at this level- and I think that there are many- things might work out great. But IMHO there are no more good scenarios for long-term holders, only those that contain either more or less pain.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.